BTG/TOB factors impact deadenylases
- 13 October 2009
- journal article
- review article
- Published by Elsevier
- Vol. 34 (12) , 640-647
- https://doi.org/10.1016/j.tibs.2009.07.008
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Structural Basis for the Antiproliferative Activity of the Tob-hCaf1 ComplexJournal of Biological Chemistry, 2009
- ANA Deficiency Enhances Bone Morphogenetic Protein-induced Ectopic Bone Formation via Transcriptional EventsJournal of Biological Chemistry, 2009
- Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activityNucleic Acids Research, 2008
- A role for Caf1 in mRNA deadenylation and decay in trypanosomes and human cellsNucleic Acids Research, 2008
- The BTG2 protein is a general activator of mRNA deadenylationThe EMBO Journal, 2008
- Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylasesGenes & Development, 2007
- The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1The EMBO Journal, 2007
- The 1.4-A crystal structure of the S. pombe Pop2p deadenylase subunit unveils the configuration of an active enzymeNucleic Acids Research, 2007
- The highways and byways of mRNA decayNature Reviews Molecular Cell Biology, 2007
- The Mammalian Immediate-early TIS21 Protein and the Leukemia-associated BTG1 Protein Interact with a Protein-arginine -MethyltransferaseJournal of Biological Chemistry, 1996